AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
As of today, AstraZeneca(AZN) shares are valued at $157.22. The company's market cap stands at 245.96B, with a P/E ratio of 25.18 and a dividend yield of 1.85%.
On 2026-08-04, AstraZeneca(AZN) stock moved within a range of $153.41 to $162.75. With shares now at $157.22, the stock is trading +2.5% above its intraday low and -3.4% below the session's peak.
Trading activity shows a volume of 16.31M, compared to an average daily volume of 3.92M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
AZN News
Biotech and Pharma Feature More Biotech M&A Is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not In this article BMY GSK 524715 LLY AZN Bristol M...
...
TD Cowen analyst Steve Scala doesn’t see logic in combination of AstraZeneca (AZN) and Bristol Myers (BMY). If combined, AstraZeneca’s 2027-2032 sales growth wo...
Analyst ratings
81%
of 31 ratingsMore AZN News
The news took the healthcare sector by storm, and the merger would position AstraZeneca as the world’s fourth-largest drugmaker by market capitalization. Prior...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confi...
A potential AstraZeneca (AZN) acquisition of Bristol-Myers Squibb (BMY) is unlikely to happen now after a report that the pharma giants have held deal talks, ac...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
The potential combination could create a pharmaceutical giant valued at nearly $400 billion. AstraZeneca holds an estimated market capitalization of $263 billio...
Wall Street Skepticism Meets Pharma Mega-Merger Rumors Reacting to reports of the massive transaction, Cramer asked in a post on X if the ongoing talks were an...
AstraZeneca (AZN) tops pharmaceutical growth rankings while Bristol Myers Squibb (BMY) trails, as the two drugmakers reportedly explore a potential merger that...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.